INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

26,158 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
31
LA
Laszlo Arthur Jr.President, Data Centers
MODMODINE MANUFACTURING CO
Open-market sale
SELL$266K
900 sh
Jun 1, 2026Jun 2, 2026
Page 339 of 654
← PrevNext →
traded Jun 1, 2026
+1d
SEC Form 4

Evidence

31
DS
Dotan SaarEVP Countries & Business Devel
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$493K
20.0K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

29
ZY
Zeng YanChief Financial Officer
ATHMAutohome Inc.
Open-market sale
SELL$106K
24.3K sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

28
BA
Bruggeworth Robert ADirector, President and CEO
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$2.84M
28.5K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

28
FJ
Fernandes Neil JSenior Vice President
LRCXLAM RESEARCH CORP
Open-market sale · 10b5-1 plan
SELL$2.37M
7,659 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

27
JI
Jeddi ImanSVP & GM da Vinci Platforms &
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$2.37M
5,625 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

26
XB
Xiang BiboChief Technology Officer
ATHMAutohome Inc.
Open-market sale
SELL$46K
10.5K sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

26
BH
Ber HedvaGlobal COO & Deputy CEO
ETOReToro Group Ltd.
Open-market sale · 10b5-1 plan
SELL$2.31M
55.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

25
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$354K
2,261 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

25
LC
Lightheart CharmaineEVP/CRDEO
RVSBRIVERVIEW BANCORP INC
Open-market purchase
BUY$145
26 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

25
LC
Lightheart CharmaineEVP/CRDEO
RVSBRIVERVIEW BANCORP INC
Open-market purchase
BUY$831
150 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

24
BA
Bruggeworth Robert ADirector, President and CEO
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$1.31M
13.0K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

24
BA
Bruggeworth Robert ADirector, President and CEO
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$1.33M
13.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

23
Sylebra Capital LlcDirector
PIIMPINJ INC
Open-market sale
SELL$1.03M
7,163 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

23
Sylebra Capital LlcDirector
PIIMPINJ INC
Open-market sale
SELL$7.31M
48.5K sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

22
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.54M
16.9K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$2.66M
38.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$2.76M
40.0K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$4.10M
60.0K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$2.76M
40.0K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
XC
Xu Cong ClaireSVP, Clinical Development
NBPNovaBridge Biosciences
Open-market sale
SELL$14K
3,494 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
BA
Bruggeworth Robert ADirector, President and CEO
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$333K
3,251 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$4.10M
60.0K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$2.66M
38.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

20
AW
Allison John W IIDirector
HOMBHOME BANCSHARES INC
Open-market sale
SELL$53K
2,000 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

20
Virginia FoxxRSelf
ARLPALLIANCE RESOURCE PARTNERS LP
Purchase
BUY$1,001 – $15KMay 15, 2026Jun 2, 2026
traded May 15, 2026
+18dHouse PTR

Evidence

19
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$324K
1,432 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

19
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$380K
4,159 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

19
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$279K
1,216 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

17
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$1.71M
25.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

17
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$1.71M
25.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

16
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$133K
584 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

16
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$110K
491 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

16
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$91K
400 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

16
YM
Yi Boyer Jennifer MEVP Entrprs Enblmnt, Ch HR Off
INGNInogen Inc
Open-market sale · 10b5-1 plan
SELL$70K
10.8K sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

16
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$152K
677 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

16
PJ
Petley Richard JChief Revenue Officer
TDCTERADATA CORP /DE/
Open-market sale · 10b5-1 plan
SELL$568K
16.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

15
FH
Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
HQYHEALTHEQUITY, INC.
Open-market sale · 10b5-1 plan
SELL$298K
3,142 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

14
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$819K
12.6K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

14
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$819K
12.6K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence